PDF herunterladen
CC BY-NC-ND 4.0 · Journal of Diabetes and Endocrine Practice 2022; 05(03): 104-111
DOI: 10.1055/s-0042-1759643
Original Article

Diagnosis and Management of Polycystic Ovary Syndrome: A Survey of Physicians from the Middle East and Africa

Salem A. Beshyah 
1   Department of Medicine, College of Medicine and Health Sciences, Khalifa University, Abu Dhabi, United Arab Emirates
2   Department of Medicine, Dubai Medical College, Dubai, United Arab Emirates
3   Department of Medicine, Yas Clinic Khalifa City, Abu Dhabi, United Arab Emirates
,
Mohammed Bashir
4   Department of Medicine, Hamad Medical Corporation, Qatar Metabolic Institute, Doha, Qatar
,
Aishah Ekhzaimy
5   Endocrinology Division, Department of Medicine, King Saud University, King Saud University Medical City, Riyadh, Saudi Arabia
,
Abbas Ali Mansour 
6   Faiha Specialized Diabetes, Endocrine and Metabolism Center (FDEMC), University of Basrah, Basrah, Iraq
,
Huda E. Mustafa
7   Health Plus Center for Diabetes and Endocrinology, Abu Dhabi, United Arab Emirates
,
Nancy Elbarbary
8   Pediatric Diabetes and Endocrinology Unit, Department of Pediatrics, Faculty of Medicine, Ain Shams University, Cairo, Egypt
,
Ghina Ghazeeri
9   Department of Obstetrics and Gynecology, American University of Beirut Medical Center, Beirut, Lebanon
,
Hisham Mohamed Abdel Rahim
10   Department of Medicine, Ribat University Hospital, Khartoum, Sudan
,
Dima K. Abdelmannan
2   Department of Medicine, Dubai Medical College, Dubai, United Arab Emirates
› Institutsangaben Funding and Sponsorship No funding was received in the publication of this study.
› Weitere Informationen
Auch verfügbar auf
   Lizenzen und Reprints

Abstract

Background Studies from several regions examined the approach to diagnosing and managing polycystic ovary syndrome (PCOS). Limited data are available from the Middle East and Africa (MEA).

Objective The aim of this study was to understand the practice pattern for diagnosing and managing PCOS by relevant specialists across the MEA region.

Methods We used an online survey consisting of an established questionnaire. The questionnaire consisted of 25 questions grouped to capture information on (a) the characteristics of the respondents, (b) patients with PCOS seen by respondents, (c) the diagnostic criteria, (d) biochemical parameters for differential diagnosis of hyperandrogenism, (e) long-term concerns, and, finally (f) management choices.

Results A total of 190 questionnaires were available for final analysis; 73.7% of the respondents were senior physicians; 59.5% and 17.4% were endocrinologists and gynecologists, respectively. Menstrual irregularity was the most frequent criterion used for the diagnosis of PCOS (90.5%), followed by hirsutism (75.7%), and biochemical hyperandrogenism (71.4%). Dehydroepiandrosterone was the most frequent biochemical parameter used for the differential diagnosis of hyperandrogenism (52.4%) followed by total testosterone (45.4%). Obesity and type 2 diabetes mellitus were the principal long-term concerns for PCOS (45.1%), followed by infertility (29.9%). Metformin was the most commonly prescribed treatment (43.8%), followed by lifestyle modification (27.0%), and oral contraceptives (18.9%). Infertility treatments include metformin alone, clomiphene citrate alone, or their combination prescribed by 23.1, 9.9, or 52.7%, respectively, whereas only 3.8% contemplated ovulation induction. Some differences and similarities were observed in previous studies, including gynecologists and endocrinologists.

Conclusions This survey provides a baseline for the perspective in diagnosing and treating PCOS in the MEA region. Some deviation is observed from mainline recommended practices. More education on PCOS diagnostic criteria and treatment of PCOS is needed in line with the recently published evidence international guideline.

Keywords

polycystic ovary syndrome - clinical practices - metabolic syndrome - antiandrogens - MENA region - Africa

Authors' Contributions

The named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship of this manuscript (conception, data collection, and drafting/revision of the article). They take responsibility for the integrity of the work and have given final approval for the version of the manuscript.


Compliance with Ethical Principles

The study was approved by the Institutional Review Board of Sheikh Khalifa Medical City, Abu Dhabi, UAE. Informed consent was received from the participants before they take the questionnaire.


Supplementary Material



Publikationsverlauf

Artikel online veröffentlicht:
22. Dezember 2022

© 2023. Gulf Association of Endocrinology and Diabetes (GAED). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Azziz R. Polycystic ovary syndrome. Obstet Gynecol 2018; 132 (02) 321-336
    CrossrefPubMedGoogle Scholar
  • 2 Meier RK. Polycystic ovary syndrome. Nurs Clin North Am 2018; 53 (03) 407-420
    CrossrefPubMedGoogle Scholar
  • 3 Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol 2018; 14 (05) 270-284
    CrossrefPubMedGoogle Scholar
  • 4 Bednarska S, Siejka A. The pathogenesis and treatment of polycystic ovary syndrome: what's new?. Adv Clin Exp Med 2017; 26 (02) 359-367
    CrossrefPubMedGoogle Scholar
  • 5 Ortiz-Flores AE, Luque-Ramírez M, Escobar-Morreale HF. Polycystic ovary syndrome in adult women. Med Clin (Barc) 2019; 152 (11) 450-457
    PubMedGoogle Scholar
  • 6 The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19: 41-47
    CrossrefPubMedGoogle Scholar
  • 7 Legro RS, Arslanian SA, Ehrmann DA. et al; Endocrine Society. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2013; 98 (12) 4565-4592
    CrossrefPubMedGoogle Scholar
  • 8 Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E. American Association of Clinical Endocrinologists (AACE), American College of Endocrinology (ACE), Androgen Excess and PCOS Society. American College of Endocrinology (ACE); Androgen Excess and PCOS Society. American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and Pcos Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome - Part 2. Endocr Pract 2015; 21 (12) 1415-1426
    CrossrefPubMedGoogle Scholar
  • 9 Ibáñez L, Oberfield SE, Witchel S. et al. An International Consortium Update: pathophysiology, diagnosis, and treatment of polycystic ovarian syndrome in adolescence. Horm Res Paediatr 2017; 88 (06) 371-395
    CrossrefPubMedGoogle Scholar
  • 10 Teede HJ, Misso ML, Costello MF. et al; International PCOS Network. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril 2018; 110 (03) 364-379
    CrossrefPubMedGoogle Scholar
  • 11 American College of Obstetricians and Gynecologists' Committee on Practice Bulletins—Gynecology. ACOG Practice Bulletin No. 194: polycystic ovary syndrome. Obstet Gynecol 2018; 131 (06) e157-e171
    CrossrefPubMedGoogle Scholar
  • 12 Abdel-Rahman MY, Jackson LW, Rodewald KJ, Abdellah MA, Ismail SA, Hurd WW. Polycystic ovary syndrome and diabetes screening: a survey of gynecologists and reproductive endocrinologists. Eur J Obstet Gynecol Reprod Biol 2012; 162 (02) 178-181
    CrossrefPubMedGoogle Scholar
  • 13 Conway G, Dewailly D, Diamanti-Kandarakis E. et al; ESE PCOS Special Interest Group. European survey of diagnosis and management of the polycystic ovary syndrome: results of the ESE PCOS Special Interest Group's Questionnaire. Eur J Endocrinol 2014; 171 (04) 489-498
    CrossrefPubMedGoogle Scholar
  • 14 Dokras A, Saini S, Gibson-Helm M, Schulkin J, Cooney L, Teede H. Gaps in knowledge among physicians regarding diagnostic criteria and management of polycystic ovary syndrome. Fertil Steril 2017; 107 (06) 1380-1386.e1
    CrossrefPubMedGoogle Scholar
  • 15 Gibson-Helm M, Dokras A, Karro H, Piltonen T, Teede HJ. Knowledge and practices regarding polycystic ovary syndrome among physicians in Europe, North America, and internationally: an online questionnaire-based study. Semin Reprod Med 2018; 36 (01) 19-27
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 16 Piltonen TT, Ruokojärvi M, Karro H. et al. Awareness of polycystic ovary syndrome among obstetrician-gynecologists and endocrinologists in Northern Europe. PLoS One 2019; 14 (12) e0226074 DOI: 10.1371/journal.pone.0226074.
    CrossrefPubMedGoogle Scholar
  • 17 Al-Ruhaily AD, Malabu UH, Sulimani RA. Hirsutism in Saudi females of reproductive age: a hospital-based study. Ann Saudi Med 2008; 28 (01) 28-32
    PubMedGoogle Scholar
  • 18 Sharif E, Rahman S, Zia Y, Rizk NM. The frequency of polycystic ovary syndrome in young reproductive females in Qatar. Int J Womens Health 2016; 9: 1-10
    CrossrefPubMedGoogle Scholar
  • 19 Beshyah SA, Sherif IH, Mustafa HE, Saadi HF. Patterns of clinical management of hypothyroidism in adults: an electronic survey of physicians from the Middle East and Africa. J Diabetes Endocr Pract 2021; 4: 75-82
    Artikel in Thieme ConnectGoogle Scholar
  • 20 Beshyah SA, Ali KF. Management of adrenal insufficiency: a survey of perceptions and practices of physicians from the Middle East and North Africa. J Diabetes Endocr Pract 2021; 4 (03) 125-130
    Artikel in Thieme ConnectGoogle Scholar
  • 21 Beshyah SA, Khalil A. Clinical practice patterns in the management of thyroid nodules: the first survey from the Middle East and Africa. J Diabetes Endocr Pract 2021; 04 (04) 167-174
    Artikel in Thieme ConnectGoogle Scholar
  • 22 Alzamil H, Aloraini K, AlAgeel R. et al. Disparity among endocrinologists and gynaecologists in the diagnosis of polycystic ovarian syndrome. Sultan Qaboos Univ Med J 2020; 20 (03) e323-e329
    CrossrefPubMedGoogle Scholar
  • 23 Cussons AJ, Stuckey BG, Walsh JP, Burke V, Norman RJ. Polycystic ovarian syndrome: marked differences between endocrinologists and gynaecologists in diagnosis and management. Clin Endocrinol (Oxf) 2005; 62 (03) 289-295
    CrossrefPubMedGoogle Scholar
  • 24 Yan D, Yan-Fang W, Shi-Yang Z. et al. Is polycystic ovary syndrome appropriately diagnosed by obstetricians and gynaecologists across China: a nationwide survey. J Ovarian Res 2021; 14 (01) 25 DOI: 10.1186/s13048-021-00780-6.
    CrossrefPubMedGoogle Scholar